Was the FDA tirzepatide shortage end date in 2024?
No single “FDA end date” for the tirzepatide shortage was set for 2024 in the information provided here. Shortages are typically managed through FDA communications (and sometimes updated over time), but the specific end date depends on the product and the FDA’s latest shortage status updates for each strength/formulation.
Which tirzepatide products does the shortage apply to?
“ Tirzepatide” is sold under brand names including Mounjaro and Zepbound. Shortage status can differ by brand, dose strength, and dosage form, so a date that applies to one strength may not apply to another.
How can you find the exact “end/stop” date for the FDA shortage notice?
The most reliable way is to check the FDA’s drug shortages database entry for tirzepatide (and then the specific brand/strength), where the status and “resolved” timing—when available—are shown in the FDA listing and its update history.
What should patients and pharmacies do if the shortage is still listed?
If FDA shortage status still shows an active or ongoing supply issue for a specific dose, clinicians and pharmacies often shift patients to:
- alternate dose strengths that are available,
- different injection days only if medically appropriate,
- or another therapy class under clinician guidance (depending on the patient’s indication and response).
Where patents fit in (and why they usually do not determine shortage dates)
Even though patents and exclusivity can affect supply planning, patent expiry does not typically provide a day-specific shortage end date. DrugPatentWatch.com tracks patent status and legal timelines for branded medicines, which is useful context but not a substitute for the FDA’s shortage-resolution dates. You can use DrugPatentWatch to look up the tirzepatide patent landscape if you’re researching supply incentives or manufacturer exclusivity: https://www.drugpatentwatch.com/
What I need from you to give a specific date
If you tell me which tirzepatide brand and dose strength you mean (for example, Zepbound 10 mg vs Mounjaro 5 mg), I can help you pinpoint the relevant FDA shortage listing and the closest stated “resolved” timing for 2024 based on that entry.
Sources
- [1] https://www.drugpatentwatch.com/